相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Michael G. Hanna et al.
LANCET NEUROLOGY (2019)
PSYCHOMETRIC VALIDATION OF A PATIENT-REPORTED MEASURE OF PHYSICAL FUNCTIONING IN SPORADIC INCLUSION BODY MYOSITIS
Valerie Williams et al.
MUSCLE & NERVE (2016)
DEVELOPMENT OF THE SPORADIC INCLUSION BODY MYOSITIS PHYSICAL FUNCTIONING ASSESSMENT
Carla Demuro et al.
MUSCLE & NERVE (2016)
Sporadic inclusion-body myositis: Recent advances and the state of the art in 2016
L. Gallay et al.
REVUE NEUROLOGIQUE (2016)
An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
Estelle Lach-Trifilieff et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Inclusion Body Myositis
Mazen M. Dimachkie et al.
NEUROLOGIC CLINICS (2014)
Treatment of sporadic inclusion body myositis with bimagrumab
Anthony A. Amato et al.
NEUROLOGY (2014)
Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
Rosamund C. Smith et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2013)
Update on sporadic inclusion body myositis
Reinhard Hohlfeld
BRAIN (2011)
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities
Fieke M. Cox et al.
BRAIN (2011)
Long-term observational study of sporadic inclusion body myositis
Olivier Benveniste et al.
BRAIN (2011)
Inclusion body myositis
D. Hilton-Jones et al.
NEUROMUSCULAR DISORDERS (2010)
分享论文
